MannKind begins patient enrolment in INHALE-1ST pa...
Category : Clinical Trial Update 11 February 2026"MannKind Corporation, a biopharmaceutical company dedicated to transforming chronic disease ca...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Kashiv BioSciences and Intas Pharma ink exclusive...
Category : Clinical Trial Update 11 February 2026"Kashiv BioSciences, LLC (Kashiv), a vertically integrated biopharmaceutical company, announced...
Roche’s phase III FENtrepid study of fenebrutinib...
Category : Clinical Trial Update 11 February 2026"Roche announced new late-breaking data from the phase III FENtrepid study showing the investig...
MerryLife Reports Positive Phase 1 Data for Oral A...
Category : Clinical Trial Update 10 February 2026MerryLife Biomedical Inc. announced positive Phase 1 results for TML-6, its investigational oral the...
FDA Issues CRL for REGENXBIO’s RGX-121 in Hunter S...
Category : Clinical Trial Update 10 February 2026The US FDA has issued a Complete Response Letter (CRL) for RGX-121 (clemidsogene lanparvovec), REGEN...
Latest Newsletter Post
-
Roche’s phase III FENtrepid study o..
11 February 2026
-
Kashiv BioSciences and Intas Pharma..
11 February 2026
-
MannKind begins patient enrolment i..
11 February 2026
-
Innocan Publishes Placebo-Controlle..
10 February 2026
-
FDA Issues CRL for REGENXBIO’s RGX-..
10 February 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com